WCN26-3454 Clinical correlation of copeptin among diabetes mellitus patients with progressive nephropathy towards End Stage Renal Disease

Read full text Summarise with VIRAT
Authors: Muhammad Tassaduq Khan, Tooba Noor, Farina Muhammad Hanif
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Diabetic nephropathy is the leading cause of End Stage Renal Disease. Arginine Vasopressin (AVP) plays pivotal role in osmoregulation and renal water conservation. As diabetic patients are prone to develop renal complications, AVP system is considered as a novel target to be evaluated for possible disruption. Copeptin, a surrogate biomarker of AVP, is preferred over AVP due to comparatively stable structure and prolonged half-life.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Electrolyte and hormonal disorders Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104738–104738
Publication date
25 March 2026
Language
EN